Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.1%
Product Images NDC 72934-2094

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.1% (NDC 72934-2094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fd (2 End)

FDA Label Image

Sdf (2094 2 Front)

FDA Label Image

Xz (2094 2 Middle)

Xz (2094 2 Middle)
This appears to be a product label or information for a drug or cream. The lot number, batch codes, and manufacturing date are provided. The active ingredients listed are hyaluronic acid sodium salt and TazZarotene, but the quantities are not stated. The other ingredients are listed as "Suspendisse cream." Without further context, it is not possible to provide a more detailed description of this product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.